Conference on Cell and Gene Therapy for HIV Cure

August 26-27, 2014 | Fred Hutchinson Cancer Research Center | Seattle, WA

Download: CGT4HIVCure 2014 Program Booklet

cgt4hivcure2014bookletcover

Conference Agenda

DAY 1: Tuesday, August 26, 2014

PELTON AUDITORIUM

7:00-8:00 am Registration and Continental Breakfast
8:00–8:15 Conference Welcome: Keith R. Jerome, MD, PhD; Hans-Peter Kiem, MD, FACP
8:15-8:45 Plenary Speaker: Lawrence Corey, MD
Fred Hutchinson Cancer Research Center, University of Washington
SESSION 1
HIV Cure History and Challenges
8:45-9:15 Steven G. Deeks, MD
University of California, San Francisco
9:15-9:45 John A. Zaia, MD
Beckman Research Institute of City of Hope
9:45-10:15 M. Juliana McElrath, MD, PhD
Fred Hutchinson Cancer Research Center, University of Washington
10:15-10:30 BREAK
Keynote
10:30-10:45 Introduction: Keynote Speaker – Lawrence Corey, MD
10:45-11:45 Keynote Speaker: Françoise Barré-Sinoussi, PhD
Inserm and Institut Pasteur
11:45-1:00 pm LUNCH: Weintraub B-Suites
SESSION 2
Vaccines and Antibodies

1:00-1:30 Galit Alter, PhD
Ragon Institute of MGH, MIT and Harvard
1:30-1:45 Leonidas Stamatatos, PhD
Seattle Biomedical Research Institute
1:45-2:00 Katherine Williams, PhD
Fred Hutchinson Cancer Research Center
SESSION 3
Inflammation
2:00-2:30 Nichole Klatt, PhD
University of Washington
2:30-2:45 Joumana Zeidan, PhD
Case Western Reserve University (work performed at Vaccine & Gene Therapy Insitute of Florida)
2:45-3:00 Laura Richert-Spuhler, PhD
University of Washington
3:00-3:15 BREAK
SESSION 4
HIV Integration and Latency
3:15-3:45 Jonathan Karn, PhD
Case Western Reserve University
3:45-4:15 Jerome Zack, PhD
University of California, Los Angeles
4:15-4:45 Lisa M. Frenkel, MD
University of Washington, Seattle Children’s Research Institute
4:45-5:00 Debbie Ruelas, MS
University of California, San Francisco
5:00-5:15 Ann Chahroudi, MD, PhD
Emory University
MOHAI
5:45-7:00 POSTERS Cocktails and Hors d’Oeuvres
7:00-9:00 DINNER
9:00-11:00 Gallery Access

DAY 2: Wednesday, August 27, 2014

PELTON AUDITORIUM
7:30–8:00 am Registration and Continental Breakfast
8:00-8:30 Plenary Speaker: J. Keith Joung, MD, PhD
Massachusetts General Hospital, Harvard Medical School
Session 5
Genome Editing
8:30-9:00 Paula Cannon, PhD
University of Southern California
9:00-9:15 Colin Exline, PhD
University of Southern California
9:15-9:30 George Llewellyn, PhD
University of Southern California
9:30-9:45 Christopher W. Peterson, PhD
Fred Hutchinson Cancer Research Center
9:45-10:00 Michael C. Holmes, PhD
Sangamo BioSciences
10:00-10:15 BREAK
SESSION 6
Vector Based Gene Therapy
– I
10:15-10:45 Ronald Mitsuyasu, MD
University of California, Los Angeles
10:45-11:00 David L. DiGiusto, PhD
Beckman Research Institute of City of Hope
11:00-11:15 Bryan Burke, PhD
Calimmune
11:15-11:30 Scott G. Kitchen, PhD
University of California, Los Angeles
11:30-1:00 pm LUNCH: Weintraub B-Suites
SESSION 7
Vector Based Gene Therapy – II
1:00-1:30 André Lieber, MD, PhD
University of Washington
1:30-1:45 Jennifer E. Adair, PhD
Fred Hutchinson Cancer Research Center
1:45-2:00 Edward Berger, PhD
National Institute of Allergy and Infectious Diseases
2:00-2:15 Mustafa Ghanem
National Institute of Allergy and Infectious Diseases
2:15-2:30 Fadila Bouamr, PhD
National Institute of Allergy and Infectious Diseases
2:30-3:00 Hans-Peter Kiem, MD, FACP
Fred Hutchinson Cancer Research Center, University of Washington
3:00-3:15 CLOSING REMARKS
PELTON AUDITORIUM
Community Event with Nobel Laureate Francoise Barre-Sinoussi
7:00-8:30 In conversation with local journalist Rosette Royale, Dr. Barre-Sinoussi will talk about the current international efforts toward an HIV Cure and the global initiative “Towards an HIV Cure” that she is leading that importantly addresses the need of engaging the communities of people living with HIV in this quest. Additionally, she will discuss how she has fought HIV by advocating for gay rights, calling for the decriminalization of drug addiction, and challenging the Vatican’s anti-condom views.Please see the Community Event page for more details

Back to Top